In 2009, an open-label pilot study demonstrated improved analgesia of flexible dose MoxDuoIR (individual doses up to 24mg morphine/16mg oxycodone) compared ...
Journal of American Medical Association (subscription) - Bridget M. Kuehn - 17 hours ago
In February 2009, the US Food and Drug Administration (FDA) announced that it was requiring manufacturers of extended-release and long-acting opioids to ...
FDA inspections have uncovered a number of violations of Good Manufacturing Practices, causing KV Pharmaceuticals to notify the FDA on December 19, ...
This February 16 companies were asked to come up with risk-management plans for prescription painkillers like morphine, oxycodone, and methadone which ...
The poster, entitled, “Tamper-Resistant Properties and Bioavailability of a Novel, Multiparticulate, Extended-Release Formulation of Oxycodone for the ...
A study published in the Annals of Internal Medicine has found that doctors are increasingly prescribing oxycodone, morphine and other opioid painkillers ...
Excluding $96 million in sales of oxycodone hydrochloride extended-release tablets (Oxy ER) in the first-quarter 2009, first-quarter 2010 net sales grew 11% ...
Morphine, oxycodone, and oxymorphone — different chemical compounds that all share a common mechanism of action — the binding to opioid receptors to ...
Email this story
